Cargando…
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
Long-term anticoagulation is recommended in idiopathic pulmonary arterial hypertension (IPAH). In contrast, limited data support anticoagulation in pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc-PAH). We assessed the effect of warfarin anticoagulation on survival in IP...
Autores principales: | Preston, Ioana R., Roberts, Kari E., Miller, Dave P., Sen, Ginny P., Selej, Mona, Benton, Wade W., Hill, Nicholas S., Farber, Harrison W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689180/ https://www.ncbi.nlm.nih.gov/pubmed/26510696 http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018435 |
Ejemplares similares
-
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
por: Hill, Nicholas S., et al.
Publicado: (2022) -
Biodegradation of Mixed PAHs by PAH-Degrading Endophytic Bacteria
por: Zhu, Xuezhu, et al.
Publicado: (2016) -
PAH Exposure
por: Fowler, Paul A., et al.
Publicado: (2009) -
PAH cleanup in Illinois.
por: O'Brien, J P
Publicado: (1994) -
The accumulation of metals, PAHs and alkyl PAHs in the roots of Echinacea purpurea
por: Pretorius, Travers R., et al.
Publicado: (2018)